STUDY TREATMENT: Lymphocyte count >= 300/uL within 14 days prior to the first study treatment.
Obtained within 14 days of the first study treatment: Lymphocyte count > 500/uL
Obtained within 14 days of the first study treatment: Lymphocyte count >500/uL
Obtained within 14 days prior to the first study treatment (cycle 1, day 1): lymphocyte count >= 500/uL
Obtained within 14 days prior to the first study treatment (cycle 1, day 1): platelet count >= 100,000/uL
Within 14 days prior to cycle 1 day 1 of treatment: Absolute lymphocyte count >= 500/uL
Within 14 days prior to cycle 1 day 1 of treatment: Platelet count >= 100,000/uL
Within 14 days prior to the first study treatment (cycle 1, day 1): Lymphocyte count >= 300/uL
Absolute lymphocyte count >= 500 cells/uL (obtained within 28 days prior to first study treatment)
Lymphocyte count ? 300/uL within 14 days prior to the first study treatment (cycle 1, day 1)
Platelet count ? 100,000/uL within 14 days prior to the first study treatment (cycle 1, day 1)
Within 14 days prior to the first study treatment (cycle 1, day 1): Lymphocyte count >= 300/uL.
Absolute neutrophil count >= 1500 cells/uL, obtained within 14 days prior to the first study treatment (cycle 1, day 1)
Lymphocyte count >= 300/uL, obtained within 14 days prior to the first study treatment (cycle 1, day 1)
Platelet count >= 100,000/uL, obtained within 14 days prior to the first study treatment (cycle 1, day 1)
Lymphocyte count >= 0.5 x 10^9/L, obtained within 14 days prior to initiation of study treatment
Within 14 days prior to the first study treatment (cycle 1, day 1): Lymphocyte count >= 500/uL
Obtained within 14 days prior to the first study treatment (cycle 1, day 1); lymphocyte count ? 300/uL
Obtained within 14 days prior to the first study treatment (cycle 1, day 1); platelet count ? 75,000/uL
Lymphocyte count >= 300/uL (obtained within 14 days prior to the first study treatment [course 1, day 1])
Platelet count >= 75 x 10^3/uL obtained at baseline (day 1 of cycle 1, before study drug administration)
Absolute neutrophil count >= 1.0 x 10^3/uL obtained at baseline (day 1 of cycle 1, before study drug administration)
Lymphocyte count >= 500/uL (obtained within 28 days prior to the first study treatment)